I’m a 24 mother, nursing my 9 month old daughter and I’m afraid of getting pregnant, Dok, Is there a contraceptive pill that I can take?
Yes, you may take Lynestrenol( Exluton Tab) 1 tablet daily at the same time of the day without interruption for 28 consecutive days.May be taken with or without food.
Yes, you may take Lynestrenol( Exluton Tab) 1 tablet daily at the same time of the day without interruption for 28 consecutive days.May be taken with or without food.
SIDE-EFFECTS AND SPECIAL PRECAUTIONS
(a)
During the first few months of treatment irregular loss of blood may occur. Experience has shown that this is almost certainly a temporary problem. If it should occur, tablet taking should not be interrupted. If the irregular bleeding is severe or prolonged, the doctor should be consulted.
(b)
Occasionally menstruation fails to occur. If the tablets have been taken as directed, this will almost certainly not mean that the patient is pregnant. Tablet-taking should not be interrupted. If the bleeding is more than one month late, the patient must consult her doctor in order to rule out the possibility of pregnancy. She may of course consult her doctor earlier, if wanted.
(c)
Nausea, headache and breast tenderness may also be experienced during the initial months of treatment, but these are only temporary symptoms.
(d)
During the use of oral contraceptives the body mass may increase. Experience has shown that the body mass stabilizes after some time and, in most cases, can be easily controlled by diet.
(e)
Symptoms such as sudden and severe headache, pain in the chest, visual disturbances, and a swollen arm or leg require medical examination.
(f)
By regular medical control it is possible to detect thromboembolic processes (thrombophlebitis; cerebrovascular disorders, pulmonary embolism and retinal thrombosis) in an earlier stage. The use of the preparation should be stopped immediately in these cases.
Studies in England and in the United States have shown that women using oral contraceptives run a greater risk of thrombosis than non-users. As to how far this applies also to Exluton, which contains no oestrogenic substance, is not known. For the time being, it seems advisable to observe the same caution when using this preparation.
(g)
If jaundice should occur during the use of the product, administration should be discontinued immediately.
(h)
Since the glucose tolerance may diminish during the use of oral contraceptives, diabetic patients should be kept under strict control.
(i)
Because fluid retention may sometimes be possible during the use of the product, conditions which might be influenced by this factor, such as cardiac or renal dysfunction, epilepsy, migraine and asthma, require careful observation.
(j)
Caution should be observed in young women whose cycles are not yet established.
(k)
Since oral contraceptives may cause an increase of blood pressure in predisposed women, this should be checked regularly. In case of serious hypertension, further administration of the preparation should be withheld.
(l)
In case no withdrawal bleeding occurs it is advisable to rule out pregnancy. Important in this respect is, of course the question of whether tablets have been forgotten. If no bleeding has occurred in two consecutive cycles pregnancy should be ruled out anyway.
(m)
It is advisable to perform periodic physical examination once every 3 months during the first year of treatment and once every 6 months thereafter. These examinations should include special reference to duration of the cycle, body mass, blood pressure, breasts, pelvic organs, legs and skin
(a)
During the first few months of treatment irregular loss of blood may occur. Experience has shown that this is almost certainly a temporary problem. If it should occur, tablet taking should not be interrupted. If the irregular bleeding is severe or prolonged, the doctor should be consulted.
(b)
Occasionally menstruation fails to occur. If the tablets have been taken as directed, this will almost certainly not mean that the patient is pregnant. Tablet-taking should not be interrupted. If the bleeding is more than one month late, the patient must consult her doctor in order to rule out the possibility of pregnancy. She may of course consult her doctor earlier, if wanted.
(c)
Nausea, headache and breast tenderness may also be experienced during the initial months of treatment, but these are only temporary symptoms.
(d)
During the use of oral contraceptives the body mass may increase. Experience has shown that the body mass stabilizes after some time and, in most cases, can be easily controlled by diet.
(e)
Symptoms such as sudden and severe headache, pain in the chest, visual disturbances, and a swollen arm or leg require medical examination.
(f)
By regular medical control it is possible to detect thromboembolic processes (thrombophlebitis; cerebrovascular disorders, pulmonary embolism and retinal thrombosis) in an earlier stage. The use of the preparation should be stopped immediately in these cases.
Studies in England and in the United States have shown that women using oral contraceptives run a greater risk of thrombosis than non-users. As to how far this applies also to Exluton, which contains no oestrogenic substance, is not known. For the time being, it seems advisable to observe the same caution when using this preparation.
(g)
If jaundice should occur during the use of the product, administration should be discontinued immediately.
(h)
Since the glucose tolerance may diminish during the use of oral contraceptives, diabetic patients should be kept under strict control.
(i)
Because fluid retention may sometimes be possible during the use of the product, conditions which might be influenced by this factor, such as cardiac or renal dysfunction, epilepsy, migraine and asthma, require careful observation.
(j)
Caution should be observed in young women whose cycles are not yet established.
(k)
Since oral contraceptives may cause an increase of blood pressure in predisposed women, this should be checked regularly. In case of serious hypertension, further administration of the preparation should be withheld.
(l)
In case no withdrawal bleeding occurs it is advisable to rule out pregnancy. Important in this respect is, of course the question of whether tablets have been forgotten. If no bleeding has occurred in two consecutive cycles pregnancy should be ruled out anyway.
(m)
It is advisable to perform periodic physical examination once every 3 months during the first year of treatment and once every 6 months thereafter. These examinations should include special reference to duration of the cycle, body mass, blood pressure, breasts, pelvic organs, legs and skin